Dogwood Therapeutics, Stock Fundamentals
| DWTX Stock | 2.40 0.20 7.69% |
Dogwood Therapeutics, fundamentals help investors to digest information that contributes to Dogwood Therapeutics,'s financial success or failures. It also enables traders to predict the movement of Dogwood Stock. The fundamental analysis module provides a way to measure Dogwood Therapeutics,'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Dogwood Therapeutics, stock.
At this time, Dogwood Therapeutics,'s Net Interest Income is fairly stable compared to the past year. Selling General Administrative is likely to rise to about 4.5 M in 2024, whereas Operating Income is likely to drop (5.7 M) in 2024. Dogwood | Select Account or Indicator |
Dogwood Therapeutics, Company Total Asset Analysis
Dogwood Therapeutics,'s Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Dogwood Therapeutics, Total Asset | 4.17 M |
Most of Dogwood Therapeutics,'s fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Dogwood Therapeutics, is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Dogwood Total Asset Historical Pattern
Today, most investors in Dogwood Therapeutics, Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Dogwood Therapeutics,'s growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Dogwood Therapeutics, total asset as a starting point in their analysis.
Dogwood Therapeutics, Total Asset |
| Timeline |
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
| Competition |
Dogwood Total Assets
Total Assets |
|
Based on the latest financial disclosure, Dogwood Therapeutics, has a Total Asset of 4.17 M. This is 99.94% lower than that of the Healthcare sector and 99.79% lower than that of the Biotechnology industry. The total asset for all United States stocks is 99.99% higher than that of the company.
Dogwood Therapeutics, Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Dogwood Therapeutics,'s current stock value. Our valuation model uses many indicators to compare Dogwood Therapeutics, value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Dogwood Therapeutics, competition to find correlations between indicators driving Dogwood Therapeutics,'s intrinsic value. More Info.Dogwood Therapeutics, is rated below average in net income category among its peers. It is rated below average in total debt category among its peers . Dogwood Therapeutics, reported Net Loss of (5.3 Million) in 2023. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Dogwood Therapeutics,'s earnings, one of the primary drivers of an investment's value.Dogwood Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Dogwood Therapeutics,'s direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Dogwood Therapeutics, could also be used in its relative valuation, which is a method of valuing Dogwood Therapeutics, by comparing valuation metrics of similar companies.Dogwood Therapeutics, is rated below average in total asset category among its peers.
Dogwood Fundamentals
| Net Income | (5.3 M) | ||||
| Total Debt | 358.55 K | ||||
| Total Asset | 4.17 M | ||||
| Retained Earnings | (61.47 M) | ||||
| Working Capital | 3.81 M | ||||
| Net Asset | 4.17 M |
About Dogwood Therapeutics, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Dogwood Therapeutics,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dogwood Therapeutics, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dogwood Therapeutics, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Dogwood Stock Analysis
When running Dogwood Therapeutics,'s price analysis, check to measure Dogwood Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dogwood Therapeutics, is operating at the current time. Most of Dogwood Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Dogwood Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dogwood Therapeutics,'s price. Additionally, you may evaluate how the addition of Dogwood Therapeutics, to your portfolios can decrease your overall portfolio volatility.